Lung Cancer

Lung cancer is the world's most common cancer and kills more people than any other cancer. In 2008, approximately 1.52 million new cases of lung cancer were diagnosed worldwide, with 1.31 million people dying from the disease.(14) In the United States, an estimated 161,840 deaths, accounting for 29 percent of all cancer deaths, occurred in 2008, according to the American Cancer Society (ACS).
Lung Cancer

Lung cancer is a common and very serious form of cancer, with more than 40,000 people diagnosed with the condition each year in the UK. The symptoms of lung cancer do not present in the early stages, but when symptoms do eventually present, they usually include the following:

Read More

Overview

Feature Articles

Latest Lung Cancer News and Research

KinaRx receives SBIR grant to speed up clinical trials for AML and other diseases

KinaRx receives SBIR grant to speed up clinical trials for AML and other diseases

Bacteria lurking in cancer cells may affect treatment

Bacteria lurking in cancer cells may affect treatment

New advance addresses a big challenge with using CRISPR in cancer patients

New advance addresses a big challenge with using CRISPR in cancer patients

A moving target identified in small cell lung tumors

A moving target identified in small cell lung tumors

New immunotherapy for metastatic non-small cell lung cancer shows promise in clinical trial

New immunotherapy for metastatic non-small cell lung cancer shows promise in clinical trial

New review analyzes appropriateness of off-pathway cancer care

New review analyzes appropriateness of off-pathway cancer care

Scientists identify factors influencing outcomes in kidney cancer patients treated with immunotherapy

Scientists identify factors influencing outcomes in kidney cancer patients treated with immunotherapy

Newer treatment approaches may reduce risk of therapy-related hematologic cancers

Newer treatment approaches may reduce risk of therapy-related hematologic cancers

Adoptive T-cell therapy targeting MAGE-A4 achieves responses in patients with multiple solid tumors

Adoptive T-cell therapy targeting MAGE-A4 achieves responses in patients with multiple solid tumors

Targeted therapy tepotinib shows durable response in NSCLC patients with METex14 skipping mutation

Targeted therapy tepotinib shows durable response in NSCLC patients with METex14 skipping mutation

Targeted therapy pralsetinib shows high response rates in patients with RET fusion-positive cancers

Targeted therapy pralsetinib shows high response rates in patients with RET fusion-positive cancers

Targeted therapy shows immense benefit for patients with early stage NSCLC

Targeted therapy shows immense benefit for patients with early stage NSCLC

Dana-Farber nurse-scientists receive more than $1.3 million for two research projects

Dana-Farber nurse-scientists receive more than $1.3 million for two research projects

New AI tool could predict risk of lung cancer recurrence

New AI tool could predict risk of lung cancer recurrence

Research looks at COVID-19 in cancer patients

Research looks at COVID-19 in cancer patients

Molecular testing rates in most countries less than 50%, IASLC survey finds

Molecular testing rates in most countries less than 50%, IASLC survey finds

Radiation oncology clinics report fewer patients despite improved safety measures

Radiation oncology clinics report fewer patients despite improved safety measures

Cancer biologists identify important drivers of tumor resistance

Cancer biologists identify important drivers of tumor resistance

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

Experts publish a review of lung cancer treatments for patients with COVID-19

Experts publish a review of lung cancer treatments for patients with COVID-19